NDUFS4 deletion triggers loss of NDUFA12 in Ndufs4−/− mice and Leigh syndrome patients: A stabilizing role for NDUFAF2 by Adjobo-Hermans, Merel J.W. et al.
Contents lists available at ScienceDirect
BBA - Bioenergetics
journal homepage: www.elsevier.com/locate/bbabio
NDUFS4 deletion triggers loss of NDUFA12 in Ndufs4−/− mice and Leigh
syndrome patients: A stabilizing role for NDUFAF2
Merel J.W. Adjobo-Hermansa, Ria de Haasb, Peter H.G.M. Willemsa, Aleksandra Wojtalac,
Sjenet E. van Emst-de Vriesa, Jori A. Wagenaarsa, Mariel van den Brandb, Richard J. Rodenburgb,
Jan A.M. Smeitinkb, Leo G. Nijtmansb,1, Leonid A. Sazanovd, Mariusz R. Wieckowskic,⁎,
Werner J.H. Koopmana,⁎⁎
a Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud Center for Mitochondrial Medicine, Radboudumc, Nijmegen, the Netherlands
bDepartment of Pediatrics, Radboud Center for Mitochondrial Medicine, Radboudumc, Nijmegen, the Netherlands
cNencki Institute of Experimental Biology, Warsaw, Poland
d Institute of Science and Technology, Klosterneuburg, Austria
A R T I C L E I N F O
Keywords:
NADH:ubiquinone oxidoreductase
Leigh syndrome
Proteomics
Fibroblasts
A B S T R A C T
Mutations in NDUFS4, which encodes an accessory subunit of mitochondrial oxidative phosphorylation
(OXPHOS) complex I (CI), induce Leigh syndrome (LS). LS is a poorly understood pediatric disorder featuring
brain-specific anomalies and early death. To study the LS pathomechanism, we here compared OXPHOS pro-
teomes between various Ndufs4−/− mouse tissues. Ndufs4−/− animals displayed significantly lower CI subunit
levels in brain/diaphragm relative to other tissues (liver/heart/kidney/skeletal muscle), whereas other OXPHOS
subunit levels were not reduced. Absence of NDUFS4 induced near complete absence of the NDUFA12 accessory
subunit, a 50% reduction in other CI subunit levels, and an increase in specific CI assembly factors. Among the
latter, NDUFAF2 was most highly increased. Regarding NDUFS4, NDUFA12 and NDUFAF2, identical results
were obtained in Ndufs4−/− mouse embryonic fibroblasts (MEFs) and NDUFS4-mutated LS patient cells.
Ndufs4−/− MEFs contained active CI in situ but blue-native-PAGE highlighted that NDUFAF2 attached to an
inactive CI subcomplex (CI-830) and inactive assemblies of higher MW. In NDUFA12-mutated LS patient cells,
NDUFA12 absence did not reduce NDUFS4 levels but triggered NDUFAF2 association to active CI. BN-PAGE
revealed no such association in LS patient fibroblasts with mutations in other CI subunit-encoding genes where
NDUFAF2 was attached to CI-830 (NDUFS1, NDUFV1 mutation) or not detected (NDUFS7 mutation). Supported
by enzymological and CI in silico structural analysis, we conclude that absence of NDUFS4 induces near complete
absence of NDUFA12 but not vice versa, and that NDUFAF2 stabilizes active CI in Ndufs4−/−mice and LS patient
cells, perhaps in concert with mitochondrial inner membrane lipids.
1. Introduction
Mitochondrial complex I (CI or NADH:ubiquinone oxidoreductase;
EC 1.6.5.3) is the first and largest (~1 MDa) complex of the oxidative
phosphorylation (OXPHOS) system, which further consists of four other
multi-subunit complexes (CII-CV; [1]). CI transfers electrons from
NADH to ubiquinone and uses the energy released by this process to
convey protons (H+) from the mitochondrial matrix across the mi-
tochondrial inner membrane (MIM). This process contributes to estab-
lishment of a trans-MIM proton-motive force (PMF) that is used to
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generate ATP by chemiosmotic coupling [2]. CI consists of three func-
tional modules [3]: the N-module (NADH binding and oxidation), the
Q-module (electron transfer to ubiquinone) and the P-module (proton
pumping). Structurally, CI is L-shaped and consists of 45 subunits, one
of which (NDUFAB1) occurs twice in the fully assembled complex [4,5].
For its catalytic activity CI requires 14 core proteins [6], half of which is
encoded by the mitochondrial DNA (mtDNA: MTND1, MTND2,
MTND3, MTND4, MTND4L, MTND5, MTND6) and the remainder by the
nuclear DNA (nDNA: NDUFV1, NDUFV2, NDUFS1, NDUFS2, NDUFS3,
NDUFS7, NDUFS8). In addition to this catalytic core, CI contains 30
currently-identified nDNA-encoded accessory subunits of largely un-
known function [7]. Biogenesis of CI is assisted by at least 14 nDNA-
encoded assembly factors and the current evidence suggests that its
assembly occurs by a mechanism in which five CI protein modules are
pre-formed (N, Q/Pp-a, Pp-b, Pd-a and Pd-b) and subsequently com-
bined [8]. The structural and functional architecture of CI was de-
scribed at various levels of detail in diverse biological models like the
yeast Y. lipolytica, the eubacterium Thermus thermophilus, bovine heart,
ovine heart and porcine heart [4,9–14]. At a higher level of organiza-
tion, CI forms a supramolecular assembly with CIII and CIV [15], the
structure and potential functional aspects of which were presented
[13,16–19].
Mutations in CI structural subunits induce isolated CI deficiency
(OMIM 252010) and are primarily associated with Leigh syndrome (LS;
[20,21]). This syndrome is generally characterized by neurodegenera-
tion, variable symptoms, mitochondrial dysfunction and bilateral CNS
lesions [22]. The NDUFS4 gene encodes the 18-kDa NDUFS4 (NADH-
ubiquinone oxidoreductase Fe-S protein 4) accessory subunit of CI,
which plays an important role during CI assembly and in CI stability
[23–27]. At the clinical level, NDUFS4 mutations primarily affect the
brainstem, basal ganglia and (less frequently) the cerebral cortex and
are typically associated with hypotonia, abnormal ocular movements,
visual impairment, psychomotor arrest/regression and episodes of re-
spiratory failure [28]. On average, mutations in the NDUFS4 subunit
induce a 50% reduction of CI activity in patient fibroblasts and cause
death within 10 months after birth [28].
Various Ndufs4−/− mouse models have been generated to study the
LS pathomechanism and aid the development of therapeutic strategies
[29,30]. For instance, whole-body Ndufs4−/− mice present with many
of the clinical features observed in LS patients and are widely used.
These KO animals display an isolated CI enzymatic deficiency, appear
healthy until 5 weeks after birth but die at ~7 weeks [31–33]. Inter-
estingly, mice with a specific knockout of Ndufs4 in neurons and glia
cells (NesKO mice) displayed a phenotype very similar to that of whole-
body KO mice, including progressive neuronal deterioration and gliosis
with early involvement of the olfactory bulb, cerebellum, and vestibular
nuclei [34,35]. Specific knockout of Ndufs4 in midbrain dopaminergic
(DA) neurons did not induce neurodegeneration, loss of striatal in-
nervation or obvious Parkinson's disease (PD) symptoms [36]. How-
ever, DA homeostasis was abnormal and Ndufs4−/− DA neurons were
more vulnerable to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine (MPTP), suggesting that CI deficiency might contribute
to PD pathophysiology [36]. The latter study also revealed that heart-
specific Ndufs4 knockout induces only a mild CI deficiency in vivo. The
above results, combined with the fact that: (1) lifespan was not affected
in heart-specific Ndufs4−/− mice [36,37] and (2) whole-body KO and
NesKO mice displayed near identical clinical phenotypes [34], suggest
that the clinical phenotype associated with Ndufs4 KO is primarily due
to brain abnormalities [38]. In this sense, evidence was provided that
lesions within the dorsal brain stem vestibular nucleus (VN) and deep
cerebellar fastigial nucleus (FN) contribute to dysregulation of the
central respiratory network, leading to respiratory failure and death of
Ndufs4 KO mice [35]. To gain insight into the pathomechanism of
Ndufs4 gene deletion, we applied for the first time quantitative mass
spectrometry to determine the levels of OXPHOS subunits and assembly
factors in various tissues from whole-body Ndufs4−/− mice (brain,
liver, heart, kidney, diaphragm, skeletal muscle) and analyzed LS pa-
tient cells harboring nDNA-encoded CI mutations (NDUFS1, NDUFS4,
NDUFS7, NDUFV1, NDUFA12, NDUFAF2). We demonstrate that Ndufs4
gene deletion reduces CI subunit levels and propose that NDUFAF2 and
possibly MIM lipids can stabilize active CI at the cellular level.
2. Materials and methods
2.1. Animal breeding, tissue dissection and proteomics analysis
Initial breeding pairs of heterozygous Ndufs4+/− mice [31] were
kindly donated by the Palmiter laboratory (Howard Hughes Medical
Institute, University of Washington, Seattle). Mice were group-housed
at the Central Animal Facility (CDL) of the Radboud University at 22 °C
with a day/night rhythm of 12 h. The animals had ad libitum access to
food and water and were fed on a standard animal diet (V1534-300 R/
M-H; Ssniff GmbH, Soest, Germany). Ndufs4 whole-body knockout
(Ndufs4−/−; KO) and wild-type (WT) mice were generated by crossing
heterozygote males and females as described previously [31,39]. The
genotype of the mice was confirmed by polymerase chain reaction.
Animal experiments were approved by the Committee for Animal Ex-
periments of the Radboud University Nijmegen Medical Center Nij-
megen, The Netherlands, in accordance with Dutch laws and regula-
tions and performed under the guidelines and regulations of the Dutch
Council for Animal Care. For proteomics analysis, three WT mice (2
male, 1 female) and three KO (Ndufs4−/−) mice (2 male, 1 female)
were sacrificed 6 weeks after birth by decapitation. Different tissues
were isolated and extensively washed in PBS and stored in liquid ni-
trogen. In case of the brain, a slice (1–1.5 mm thickness) was manually
dissected and contained parts of the following brain areas: cerebral
cortex, hippocampal formation, thalamus, hypothalamus, internal
capsule, optic tract and the amygdala (Allen mouse brain atlas; http://
mouse.brain-map.org/). For comparison, other organs (from 1 KO and 1
WT animal; both males) were included in the proteomics analysis: liver,
kidney, diaphragm, heart, and skeletal muscle from the hind leg (con-
taining: musculus vastus medialis, musculus gracilis, rectus femoris, mus-
culus biceps femoris, musculus semitendinosus, musculus semimembranosus
and musculus adductor). All tissues were extensively washed in PBS and
stored for further studies in liquid nitrogen. Liquid chromatography-
MS3 spectrometry (LC-MS/MS) was carried out at the Thermo Fisher
Center for Multiplexed Proteomics (Dept. of Cell Biology, Harvard
Medical School, Cambridge, MA, USA). Peptide fractions were analyzed
using an LC-MS3 data collection strategy on an Orbitrap Fusion mass
spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). A
detailed description of the proteomics analysis is provided in the Sup-
plement. Cluster analysis of the complete detected proteome (6551
proteins) demonstrated that the WT and KO animals clustered in two
distinct groups (data not shown). In this study we focused on the OX-
PHOS system. The remainder of the proteomics data will be presented
in a follow-up manuscript (in preparation).
2.2. Mouse embryonic fibroblasts
Immortalized mouse embryonic fibroblasts (MEFs) of Ndufs4 KO
and WT mice were generated previously [40]. MEFs were cultured at
37 °C in a humidified atmosphere (95% air and 5% CO2) in DMEM
medium (#10938, Invitrogen, Carlsbad, CA, USA), containing 25 mM D-
glucose and supplemented with L-glutamine (4 mM), sodium pyruvate
(1 mM), 10% (v/v) Fetal Calf Serum (FCS, Greiner Bio-one, Frick-
enhausen, Germany) and 0.1% (v/v) Gentamycin (Invitrogen).
2.3. Primary human skin fibroblasts
Human Fibroblasts were obtained following informed parental
consent and according to the relevant Institutional Review Boards from
skin biopsies of a healthy individual (CT5120) and various patients (P)
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with complex I (CI) deficiency (OMIM 252010). Control and patient
fibroblasts were previously characterized at the genetic, biochemical
and cellular level (e.g. [41–44]). All patients displayed an isolated CI
deficiency in muscle tissue and cultured fibroblasts and were negative
with respect to mitochondrial DNA (mtDNA) alterations previously
associated with CI deficiency. Patient cell lines (Supplementary Table
S1) harbored mutations in various CI structural subunits: NDUFS7 (S7-
P5175), NDUFV1 (V1-P5866), NDUFA12 (A12), NDUFS1 (S1-P6173)
and NDUFS4 (S4-P4608, S4-P5260). Also a patient with a mutation in
the CI assembly factor NDUFAF2 (AF2-P8872) was included. Fibroblasts
were cultured in Medium 199 (M199; #22340-020; Invitrogen) in a
humidified atmosphere (95% air, 5% CO2) at 37 °C. The culture
medium contained Earle's salts, 25 mM HEPES, 5.5 mM D-glucose,
0.7 mM L-glutamine, 10% (v/v) fetal calf serum, 100 IU/ml penicillin
and 100 IU/ml streptomycin.
2.4. SDS-PAGE and BN-PAGE analysis of brain slices, mouse embryonic
fibroblasts (MEFs) and patient fibroblasts
Denaturating SDS-PAGE and blue-native-PAGE (BN-PAGE) followed
by Western blotting were performed as described in the Supplement.
2.5. Data analysis, molecular graphics and protein homology structural
modeling
Comparison of proteome data between brain slices of WT and KO
animals was performed using the Benjamini-Hochberg (BH) procedure
[45]. KO/WT protein ratios with a BH-P-value< 0.05 were considered
to be significantly changed. Unless stated otherwise, all other data was
compared using an independent Student's t-test. Averages are presented
as mean ± SEM (standard error of the mean). Cluster analysis was
performed using Ward's method and the Euclidian distance [46]. Sta-
tistical and cluster analyses were carried out using OriginPro software
(OriginLab Corporation, Northampton, MA, USA). Molecular graphics
were created using the PyMOL Molecular Graphics System Version 2.0
(Schrodinger-LLC, Mannheim, Germany). The homology model for
NDUFAF2 was generated using the Phyre2 server (Protein Homology/
analogY Recognition Engine V2.0; [47]) with default settings. The
server used the cryo-EM model of Yarrowia lipolytica NDUFAF2 (chain k
in PDB 6RFQ). Ovine NDUFAF2 is 32/44% identical/similar to ovine
NDUFA12 and 38/55% to Yarrowia NDUFAF2, so the structural model
of the assembly factor in Yarrowia [14] represents a better starting
model than the homologous ovine NDUFA12 subunit. The generated
homology model was aligned to NDUFA12 subunit and thus placed in
its location within the complex (PDB 5LNK), with all the subunits
missing in the 830 kDa subcomplex removed.
3. Results
3.1. Ndufs4 gene deletion reduces the protein levels of CI structural subunits
and increases the levels of specific CI assembly factors in mouse tissues
To determine whether Ndufs4 knockout affected the protein level of
OXPHOS subunits and assembly factors, we performed a quantitative
proteome analysis of mouse tissues (brain, heart, skeletal muscle, liver,
kidney and diaphragm; Supplementary Fig. S1). Importantly, given the
brain-specific phenotype in whole-body Ndufs4 knockout (KO) mice
(see Introduction) we focused our statistical data analysis on brain
tissue (3 KO vs. 3 WT animals), to which the other tissues were com-
pared (1 KO vs. 1 WT animal). In total, the relative protein expression
level (KO/WT) of 86 different OXPHOS structural subunits was quan-
tified (Fig. 1A; Supplementary Table S2). With the exception of
NDUFV3 and NDUFAB1, knockout of Ndufs4 significantly reduced the
levels of all CI structural proteins (Fig. 1A; marked in red characters). In
contrast, Ndufs4 knockout did not reduce the levels of other OXPHOS
complex (CII-CV) subunits. With the exception of NDUFAB1, of which
CI contains two copies (α and β), all OXPHOS subunits occur only once
in each OXPHOS complex. This allows determining the relative amount
of each OXPHOS complex by calculating the average level (KO/WT) of
its constituting subunits. In brain and diaphragm, Ndufs4 knockout
reduced the average CI subunit level by more than 60% relative to WT,
whereas in liver, heart, kidney and skeletal muscle this reduction was
significantly less (Fig. 1B; left panel). In case of CII, its average subunit
level was not reduced in any of the tissues and significantly increased in
heart and kidney (Fig. 1B; right panel). Ndufs4 knockout did not gen-
erally affect the average subunit level of CIII, CIV and CV (Fig. 1C).
Proteome analysis highlighted 34 OXPHOS assembly factors (Fig. 1D;
Supplementary Table S2). Focusing on CI in the brain, Ndufs4 gene
deletion specifically increased the protein levels (KO/WT) of NDUFAF1,
NDUFAF2, ECSIT, ACAD9, FOXRED1 and TMEM186 whereas it did not
affect the levels of NDUFAF3, NDUFAF4, NDUFAF5, NDUFAF6,
NDUFAF7, NUBLP, TIMMDC1, TMEM70, TMEM126B and TMEM261.
Expression of assembly factors for other OXPHOS complexes was not
affected in KO brain, except for the CV assembly factor ATPAF2, which
also appeared increased in the other KO tissues (Fig. 1D). These results
demonstrate that Ndufs4 knockout reduces the level of CI subunits and
increases the level of specific CI assembly factors.
3.2. Ndufs4 gene deletion induces combined loss of NDUFS4 and NDUFA12
protein and increases NDUFAF2 protein levels in mouse tissues
Focusing on CI, we next compared the expression level (KO/WT) of
its structural subunits and assembly factors in brain with that of the
other tissues (Fig. 2A). In general, protein levels in the brain (x-axis)
correlated well with other tissues (y-axis; thick line: y = x). Cluster
analysis highlighted four distinct groups (Fig. 2A; colored ovals). As
expected, Ndufs4 gene knockout induced a complete loss of NDUFS4
protein in all KO tissues. However, this knockout also greatly reduced
the levels of NDUFA12 (Fig. 2A; pink oval). No NDUFS4 peptide frag-
ments were detected whereas NDUFA12 fragments were virtually ab-
sent (Supplementary Fig. S2), which demonstrates that the overall level
of this protein is greatly reduced. Relative to other CI subunits the re-
duction in brain NDUFS4 and NDUFA12 level was 12-fold larger. All KO
mice tissues displayed reduced levels of CI structural subunits (Fig. 2A;
purple oval), a moderate increase in various CI assembly factors
(Fig. 2A; orange oval), and a 2-fold higher level of the CI assembly
factor NDUFAF2 (Fig. 2A; green oval). SDS-PAGE analysis of KO brain
tissue yielded protein levels that correlated well with our proteome
analysis, and confirmed that NDUFS4 was absent, NDUFA12 levels
were greatly reduced and NDUFAF2 was increased (Supplementary Fig.
S3). Recent data suggests that functional CI is assembled via a me-
chanism in which five CI protein modules are pre-formed (N, Q/Pp-a,
Pp-b, Pd-a and Pd-b) and subsequently combined [8]. Within the CI
structure NDUFS4 is localized close to the boundary between the N- and
Q-module (Fig. 4A). Compatible with this localization, quantification of
module-specific subunit expression levels (Supplementary Table S1)
revealed that Ndufs4 knockout reduces the average subunit level (KO/
WT) of the N- and Q-module to a greater extent than that of the Pp- and
Pd-module (Fig. 2B). Collectively, these results demonstrate that the
complete absence of NDUFS4 in all tissues is associated with: (i) near
complete absence of NDUFA12, (ii) increased levels of NDUFAF2, and
(iii) reduced stability of N- to Q-module attachment.
3.3. Ndufs4 gene knockout is associated with an NDUFAF2-containing CI
subassembly that incorporates into larger OXPHOS assemblies in mouse
embryonic fibroblasts
To study the effects of Ndufs4 gene knockout on CI assembly/sta-
bility, we analyzed mouse embryonic fibroblasts (MEFs) derived from
WT and Ndufs4−/− mice [40]. Supporting our proteomics results,
NDUFS4 was not detected, NDUFA12 was greatly reduced and
NDUFAF2 was increased in KO-MEFs (Fig. 3A–B). To visualize the effect
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of Ndufs4 knockout on the levels of CI and its incorporation in OXPHOS
assemblies of higher molecular weight, we performed blue native gel
electrophoresis (BN-PAGE) of WT and KO MEFs (Fig. 3C). Given the
reduction in N- and Q-module subunits in Ndufs4−/− tissues (see
above) we detected CI using an antibody against its NDUFA9 subunit,
which is essential in stabilizing the junction between these modules
[48]. This suggested that (Fig. 3C; “NDUFA9”) WT-MEFs contain a fully
assembled “free” CI and a CI + CIII2 assembly, whereas KO-MEFs
contain a smaller CI subassembly of ~830-kDa in a free (“CI-830”) and
CIII2-attached form (“CI-830 + CIII2”). In-gel activity (IGA) analysis
demonstrated that CI was active in its free and CIII-bound form in WT-
MEFs, whereas free and CIII2-attached CI-830 were inactive in KO-MEFs
(Fig. 3C; “IGA”). In WT-MEFs, low levels of NDUFAF2 were detected in
two distinct bands associated with CI-830 (Fig. 3C; “NDUFAF2”). In KO-
MEFs, NDUFAF2 levels were much higher than in WT-MEFs and loca-
lized in three distinct bands representing CI-830, CI-830 + CIII2 and an
even larger assembly potentially containing CIV (“CI-830-CIII2-CIV?”).
The latter assembly was not detected in WT-MEFs. These BN-PAGE
results suggest that a large and parallel reduction in the levels of
NDUFS4 and NDUFA12 stimulates association of NDUFAF2 with a
catalytically inactive CI-830 subcomplex and that CI-830-NDUFAF2 is
incorporated into larger assemblies.
3.4. The loss of NDUFS4 greatly reduces NDUFA12 protein levels in
primary fibroblasts from patients with isolated CI deficiency
To determine the relevance of the findings mentioned above in
human CI deficiency, we next compared the levels of NDUFS4,
NDUFA12, NDUFAF2 and NDUFA9, as well as CI assembly/stability/
IGA patterns, in fibroblasts from LS patients. These patient cells dis-
played an isolated CI deficiency and carried mutations in NDUFS7,
NDUFV1, NDUFA12, NDUFS1, NDUFS4 and NDUFAF2 (Supplementary
Table S1).
SDS-PAGE demonstrated that NDUFS4 was undetectable in patient
cells with NDUFS4 mutations, greatly reduced in cells with NDUFS7,
NDUFV1, NDUFS1 or NDUFAF2 mutations, and not reduced in cells
with an NDUFA12 mutation (Fig. 3D). Confirming our results in
Ndufs4−/−mouse tissues and MEFs, NDUFA12 was not detected in cells
from NDUFS4 patients (Fig. 3E). For the other mutations, NDUFA12
was either not detected (NDUFA12 patient cells) or reduced (NDUFS7,
NDUFV1, NDUFS1 patient cells). NDUFAF2 was not detected in
NDUFAF2 patient cells, slightly reduced in NDUFA12 patient cells and
not reduced in NDUFS7, NDUFV1, NDUFS1 and NDUFS4 patient cells
(Fig. 3F). The levels of NDUFA9 were reduced in all cases except for
NDUFV1 patient cells (Fig. 3F).
Fig. 1. OXPHOS proteome in brain, liver, heart, kidney, diaphragm and skeletal muscle for WT and KO animals. (A) Heatmap depicting the relative protein level
(KO/WT) of OXPHOS structural subunits (y-axis) in various tissues (x-axis). The dendrogram depicts the result of a cluster analysis on OXPHOS structural subunits (y-
axis). Proteins marked in red display a significantly different expression in KO brain (BH-P < 0.05). (B) Average subunit level (KO/WT) for CI and CII in the various
tissues. Numerals indicate the number of subunits used to calculate the average level. (C) Correlation between the average subunit level (KO/WT) of CI (x-axis) and
CII (y-axis) depicted in panel B. A significant linear correlation was observed (continuous line). Dotted lines mark the 95% confidence limits of the fitted line. (D)
Same as panel B, but now for CIII, CIV and CV. (E) Same as panel A, but now for OXPHOS assembly factors. Statistics: In panel B and D significant differences with
brain (yellow column; marked ‘a’) are indicated: *P < 0.05, ***P < 0.001. For borderline significant differences the P-value is given. Non-significant differences
are marked by ‘ns’.
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Compatible with our results in Ndufs4−/− MEFs, BN-PAGE de-
monstrated that NDUFS4 patient cells contained a CI-830 subcomplex
but no fully assembled CI (Fig. 3G; “NDUFA9”). In contrast, patient cells
with an NDUFV1, NDUFA12 or NDUFS1 mutation contained both fully
assembled CI and CI-830 (Fig. 3G; “NDUFA9”). Cells from the NDUFS7
and NDUFAF2 patients displayed a reduced level of fully assembled CI
but no detectable amounts of CI-830 (Fig. 3G; “NDUFA9”). Compatible
with SDS-PAGE analysis, NDUFA12 was not detected in NDUFS4 and
NDUFA12 patient cells at the height of fully assembled CI and variably
reduced in the other patients (Fig. 3G; “NDUFA12”).
Although present in control and NDUFS7 patient cells (Fig. 3F),
NDUFAF2 was not detected in the CI complex using BN-PAGE in these
cells (Fig. 3G; “NDUFAF2”). In contrast, NDUFAF2 was attached to the
CI-830 subcomplex in NDUFS4, NDUFS1 and NDUFV1 patients.
NDUFA12 patient cells displayed an association of NDUFAF2 with a
catalytically active CI assembly (Fig. 3G; arrowheads). IGA analysis
revealed that CI activity was reduced (NDUFS1, NDUFS7, NDUFV1,
NDUFA12, NDUFAF2) or not detectable (NDUFS4) at the position of
fully assembled CI (Fig. 3G; “IGA”). In addition, residual CI activity in
NDUFS4 patient cells was reduced more (i.e. to 7–14% of control) than
in NDUFA12 patient cells (42% of control; Supplementary Table S1).
Taken together, these results demonstrate that absence of NDUFS4
due to NDUFS4 mutations is associated with near complete loss of
NDUFA12 and increased levels of NDUFAF2 in LS patient cells. We
further observed that when NDUFA12 is absent, the CI assembly factor
NDUFAF2 can replace this structural subunit in the presence of NDUFS4
yielding catalytically active CI.
4. Discussion
Mutations in the NDUFS4 gene, encoding an accessory subunit of
mitochondrial complex I (CI), induce isolated CI deficiency and Leigh
syndrome (LS) in pediatric patients. Using quantitative proteomics we
here compared the level of OXPHOS subunits and assembly factors in
tissues from Ndufs4−/− mice. It was observed that Ndufs4 knockout
reduces CI subunit levels to a greater extent in brain and diaphragm
relative to liver, heart, kidney and skeletal muscle (Fig. 1B). This result,
combined with the fact that different organs display different thresh-
olds below which an OXPHOS enzymatic deficiency induces pathology
[49], suggests that the low CI subunit levels in brain, and possibly
diaphragm, are responsible for the brain-specific clinical phenotype and
breathing deficits in Ndufs4−/− mice [31–35].
4.1. Ndufs4 gene deletion does not reduce the level of NDUFV3, NDUFAB1
and subunits of OXPHOS complexes II, III, IV and V
In case of the CI subunit NDUFV3, a 10-kDa (NDUFV3-10) and 50-
kDa (NDUFV3-50) form were detected [50–52]. The number of peptides
for NDUFV3-10 and NDUFV3-50 in the brain equaled 1 and 7, respec-
tively. Therefore caution should be taken in the quantitative inter-
pretation of the KO/WT ratio for NDUFV3-10, which was reduced to
0.5475 but did not reach quantitative significance. In the ovine CI
structure only the NDUFV3-10 form was detected (Fig. 4A), suggesting
that NDUFV3-10 is a genuine CI subunit whereas NDUFV3-50 is not.
Similar to NDUFV3-10, the KO/WT ratio for NDUFAB1 (equaling
0.7804) appeared reduced relative to WT but this reduction was not
statistically significant. This might be due to two copies of the
NDUFAB1 subunit being present in CI (Fig. 4A; α and β) and one of
these being destabilized by the absence of NDUFS4 to a greater or lesser
extent. In addition, NDUFAB1 can interact with other proteins in-
cluding LYRM2 and the mitochondrial ribosome-linked proteins
MALSU1 and AltMiD51 [53]. These interactions might stabilize and
(partially) protect NDUFAB1 from degradation under NDUFS4-deficient
conditions. Although their functional role is still controversial [54], the
structures of the CI + CIII2 + CIV “supercomplex” and the
CI2 + CIII2 + CIV2 “megacomplex” were recently presented
[13,16–18]. We observed that Ndufs4−/− gene deletion greatly reduces
CI subunit levels without lowering these levels for CII, CIII, CIV and CV.
This argues against in situ structural stabilization of these complexes by
CI in our experimental model.
4.2. Ndufs4 gene deletion increases the level of specific CI assembly factors
In mouse brain, Ndufs4 knockout was paralleled by an increase in
the levels of specific CI assembly factors (NDUFAF1, NDUFAF2, ECSIT,
ACAD9, FOXRED1 and TMEM186), whereas the levels of CII, CIII, CIV
Fig. 2. CI proteome in brain, liver, heart, kidney, diaphragm and skeletal
muscle for WT and KO animals. (A) Correlation between the relative protein
level (KO/WT) of CI structural subunits and assembly factors in brain (x-axis)
vs. other tissues (y-axis; colorized symbols reflect different tissues). Cluster
analysis highlighted four distinct groups (highlighted ovals). (B) Average re-
lative protein level (KO/WT) of the N, Q, Pp and Pd modules of CI, calculated
by averaging the protein levels (KO/WT) of individual CI subunits that con-
stitute these modules. The inset depicts the location of the modules within CI.
Statistical comparisons between the protein level of the modules (KO/WT) were
performed by comparing the average data for each module across tissues (sig-
nificances marked in plain text on top), or by averaging protein levels (KO/WT)
for each individual model in each tissue (significances marked in bold text on
the right). Significant differences with the indicated modules (N,Q) are marked
by: *P < 0.05, **P < 0.01, ***P < 0.001.
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and CV assembly factors were not affected. There was one exception to
this pattern, the CV assembly factor ATPAF2 being increased in brain
and the other KO tissues of the KO animals. This might suggest that
ATPAF2 plays a role in CI assembly and/or stabilization. All of the
above factors bound to CI assembly intermediates in 143B osteo-
sarcoma cells [8]. NDUFAF1, ECSIT, ACAD9 and TMEM186 were pre-
sent in a 357-kDa intermediate together with putative assembly factor
COA1 (not detected in this study), assembly factor TMEM126b (not
altered in KO brain) and structural subunits MTND2, MTND3, NDUFC1
(not detected in this study) and NDUFC2. Later during CI assembly,
MTND6 and MTND4L bind to the 357-kDa intermediate to form the Pp-
b module [8]. The Pp-b intermediate subsequently combines with two
structural subunits (NDUFA10 and NDUFS5) and the Pd-a module,
which contains the structural subunits NDUFB1 (not detected in this
study), NDUFB5, NDUFB6, NDUFB10, NDUFB11, MTND4 and the as-
sembly factors TMEM70 (not altered in KO brain), FOXRED1 and
Fig. 3. SDS-PAGE and BN-PAGE analysis of mouse embryonic fibroblasts (MEFs) from WT and KO animals and Leigh Syndrome patients. (A) Protein level of
NDUFS4, NDUFA12 and NDUAF2 protein in whole cell homogenates from mouse embryonic fibroblasts (MEFs) derived from WT and KO animals. WT and KO bands
were part of the same typical blot, which was contrast optimized for visualization purposes. (B) Average expression level of the proteins in panel A determined from
the original, non-optimized, blots (n= 3 for both WT and KO). (C) Native gel (BN-PAGE) analysis of WT and KO MEFs (each in triplicate) depicting NDUFA9-positive
bands (top panel), CI in gel activity (IGA; middle panel), and NDUFAF2-positive bands (lower panel). Bands are marked as follows: CI (representing fully assembled
CI), CI + CIII2 (representing the CI-CIII2 supercomplex), CI-830 (representing the CI 830-kDa subcomplex), CI-830 + CIII2 (representing the CIII-attached form of CI-
830) and CI-830 + CIII2 + CIV? (representing the CIII and potentially CIV-attached form of the CI 830-kDa subcomplex). (D–G) The patient cells carried mutations in
NDUFV1 (“V1-5866”), NDUFS1 (“S1-6173”), NDUFS4 (“S4-5260” and “S4-4608”), NDUFS7 (“S7-5175”), NDUFA12 (“A12”) and NDUFAF2 (“AF2-8872”). For
comparison a typical control cell line (“CT5120”) was included. (D) SDS-PAGE analysis of whole cell homogenates depicting the levels of NDUFS4 protein. Porin was
used as a mitochondrial loading control. (E) Same as panel D but now for NDUFA12 protein. (F) Same as panel D but now for NDUFAF2 and NDUFA9 proteins using
the same samples as in panel E. (G) Native gel (BN-PAGE) analysis of the patient cell lines (from top to bottom): NDUFA9 signal, NDUFA12 signal, NDUFAF2 signal,
CI in-gel activity (IGA) signal and the level of CII (mitochondrial loading control). The positions of fully assembled CI and its 830-kDa subcomplex are marked by CI
and CI-830, respectively. The arrowheads mark active CI with bound NDUFAF2. The control sample (CT5120) was included twice (marked I and II). The blots/gels in
this figure were contrast optimized for visualization purposes. Statistics: relative to the WT condition: ***P < 0.001 (panel B).
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ATP5SL (not altered in KO brain). Most assembly factors (except
TMEM186 and COA1), dissociate from CI at the final stage of CI as-
sembly [8]. Among the assembly factors, the level of NDUFAF2 was
most highly increased in Ndufs4 knockout brain. NDUFAF2 (a.k.a.
NDUFA12L, Mimitin or B17.2L), a paralog of the NDUFA12 structural
subunit of CI, plays a role during the final phase of CI assembly and
insertion of FeS cluster N4 at the interface between the Q- and N-
module [55–57].
4.3. Ndufs4 gene deletion induces near complete loss of NDUFA12 and
increases NDUFAF2
In addition to an increase in NDUFAF2, loss of NDUFS4 was ac-
companied by near complete loss of NDUFA12 in Ndufs4−/− mouse
tissues, Ndufs4−/− MEFs and NDUFS4-mutated patient cells. In con-
trast, a similar loss of NDUFA12 was not observed in a mutated
Yarrowia lipolytica strain lacking NDUFS4 [14]. However, our mouse
and human cell data is supported by studies in HEK293T cells [7],
Fig. 4. Subunit localization, NDUFS4-NDUFA12 interaction and NDUFAF2 homology modeling using the ovine CI structure. (A) Side view of Ovis aries heart CI cryo-
EM structure (PDB accession number: 5LNK), embedded in the mitochondrial inner membrane (MIM) and highlighting the position of various structural subunits.
The NDUFS4 (red characters) and NDUFA12 (red underlined characters) subunits are depicted using a space-filling representation in cyan and green, respectively.
NDUFS4-interacting subunits (bold and underlined) and mtDNA-encoded subunits (bold and blue) are indicated. The assignment of subunits to various CI assembly
modules is highlighted by different colors: N-module (green), Q-module (yellow), Pp-module (orange) and Pd-module (blue). The inset highlights the location of the
NDUFS4 and NDUFA12 subunit. (B) A surface rendering of NDUFA12 subunit (green; a.k.a. B17.2) and the NDUFS4 subunit (cyan; a.k.a. 18-kDa) within the ovine CI
structure. Residues making contacts between these two subunits are shown as sticks with putative hydrogen bonds are shown (yellow dots). These residues are
conserved in mammals. (C) Probable binding of the NDUFAF2 assembly factor (a.k.a. B17.2L), illustrated using its homology model (space-filling, grey), to the
putative 830-kDa CI subcomplex (which lacks its N-module, NDUFA12 and NDUFS4).
M.J.W. Adjobo-Hermans, et al. BBA - Bioenergetics 1861 (2020) 148213
7
highlighting differences between yeast and mammalian cells/tissues.
Inspection of the CI ovine and bovine cryo-EM structures [4,5], de-
monstrates that NDUFS4 and NDUFA12 physically interact and straddle
the peripheral arm of CI from both sides, thereby linking its N and Q
module (Fig. 4A–B). These studies also highlighted interactions be-
tween NDUFS4 and NDUFV1, NDUFV2 (not in bovine), NDUFV3-10,
NDUFS1, NDUFS2 (not in ovine), NDUFS3, NDUFS8, NDUFA6 and
NDUFA9 (Fig. 4A; underlined subunits). All of these subunits are part of
the N- or Q-module, compatible with our observation that combined
loss of NDUFS4/NDUFA12 reduces the levels of N- and Q-module
subunits to a greater extent than the levels of Pp- and Pd-module sub-
units (Fig. 2B). In patient cells, the absence of NDUFA12 was not
Fig. 5. Integrated summary of results. Empirical data from SDS-PAGE, BN-PAGE and CI activity measurements was combined to deduce the in situ activity and
stability of MIM-embedded CI in Ndufs4−/− knockout tissues and LS patient cells with NDUFA12, NDUFS7, NDUFV1, NDUFS2, NDUFAF2 and NDUFS4 gene mu-
tations. The relative cellular level of NDUFS4, NDUFA12 and NDUFAF2 is indicated in the column marked “SDS-PAGE”. The presence of assembled and active CI (CI)
and the CI-830 subcomplex are indicated in the column marked “BN-PAGE” (see Discussion for details).
M.J.W. Adjobo-Hermans, et al. BBA - Bioenergetics 1861 (2020) 148213
8
paralleled by reduced NDUFS4 levels. This suggests that NDUFS4 sta-
bilizes NDUFA12 but not vice versa, and that the presence of NDUFS4 is
more relevant for N- to Q-module attachment than NDUFA12.
Interestingly, studies in Yarrowia lipolytica revealed that deletion of
the NUMM (NDUFS6 homolog) gene, which encodes the NUMM/
NDUFS6 accessory subunit of CI, blocks a late step in CI assembly [58].
In this model system, NUMM/NDUFS6 gene deletion was associated
with assembly of all CI core/accessory subunits except N7BM
(NDUFA12 homolog), and firm association of N7BML (NDUFAF2
homolog) with a CI assembly intermediate. It was concluded that
N7BM/NDUFA12 replaces N7BML/NDUFAF2 during complex I bio-
genesis [58]. The recently published cryo-EM structure from complex I
obtained from a mutant Yarrowia lipolytica strain lacking NDUFS6
supports these findings [14]. Previous analysis of patient cells demon-
strated that the absence of NDUFS4 and NDUFS6 induced formation of
an 800-kDa subcomplex to which NDUFAF2 was attached [55–57]. The
latter and our current findings support a mechanism based on evidence
in Neurospora crassa, which proposes that NDUFAF2 is bound to a late
CI assembly intermediate and dissociates upon binding of an
NDUFA12/NDUFS4/NDUFS6-containing “regulatory” module [59].
However, differences between yeast and mammals do exist, as ex-
emplified by the fact that, in contrast to our studies in mammals
(Ndufs4−/− mouse model and patient cells), deletion of NDUFS4 does
not lead to loss of NDUFA12 in Yarrowia lipolytica [14].
4.4. The NDUFAF2 assembly factor can function as a stabilizing structural
CI subunit
Previous results suggest that NDUFAF2 can associate with CI-830
but not with fully assembled CI [55]. In contrast, evidence in an arti-
ficial HEK293 cell model demonstrated that Ndufa12 knockout triggers
association of NDUFAF2 with active CI that appeared fully assembled
[7]. Analyzing NDUFA12 patient cells, we here observed that NDUFAF2
associates with a catalytically active CI assembly, but only in the ab-
sence of NDUFA12 and presence of NDUFS4. Analysis of residual CI
activity in mitochondria-enriched fractions (Supplementary Table S1)
revealed that this activity is reduced to a greater extent in NDUFS4
patient cells than in NDUFA12 patient cells. This suggests that
NDUFAF2 supports the formation of a catalytically active CI in the
absence of NDUFA12 protein, in agreement with the presented BN-
PAGE data revealing a complex within the same size range as in control
cells (Fig. 3G). However, the residual CI activity in NDUFA12 mi-
tochondria was 42% of control, whereas this activity was only 7–14% in
the NDUFS4 patients. This suggests that rescue by NDUFAF2 is unable
to fully restore CI catalytic activity. This provides first time evidence in
a disease-model that NDUFAF2 can act as a stabilizing structural sub-
unit by replacing NDUFA12. Homology modeling suggests how binding
of NDUFAF2/B17.2 L to the CI-830 subcomplex in the absence of
NDUFA12/B17.2 and NDUFS4 (18-kDa) subunit might occur (Fig. 4C).
To model NDUFAF2, we used the structure of Yarrowia lipolytica
NDUFAF2 that recently became available [14]. The helical extension of
NDUFAF2 could sterically hinder the interaction of NDUFS6 with nas-
cent CI. However, our findings demonstrate that the CI formed is active
and migrates at as similar height in NDUFA12 patient cells as in control
cells (Fig. 3G). Therefore, we hypothesize that NDUFS6 is able to bind,
though possibly more weakly, to a structure in which NDUFAF2 has
replaced NDUFA12.
Importantly, tissues from Ndufs4−/− mice [60] and fibroblasts from
patients with NDUFS4 mutations (Supplementary Table S1) still display
substantial CI activity measured in mitochondria-enriched fractions.
Moreover, although oxygen consumption in Ndufs4−/− MEFs is lower
than in WT-MEFs it is still acutely blocked by the CI inhibitor rotenone
[40]. This demonstrates that the absence of an IGA signal in Ndufs4−/−
MEFs and NDUFS4-mutated patient fibroblasts during BN-PAGE ana-
lysis does not reflect the in situ condition within living cells (Fig. 5). In
this sense, the fact that BN-PAGE of NDUFV1- and NDUFS1 patient cells
highlighted both fully active CI and the inactive NDUFAF2-CI-830
subcomplex, strongly suggests that NDUFAF2 stabilizes active CI in situ
(Fig. 5). This is compatible with previous studies in NDUFV1 patient
cells [55,56]. In Neurospora, knockout of NDUFS1 leads to NDUFAF2
binding to nascent CI [59]. In agreement with this model, we here
demonstrate that NDUFAF2 binds to the CI-830 subcomplex in NDUFS1
patient cells. In case of NDUFS7 patient cells, BN-PAGE analysis re-
vealed a reduced level of active CI but no NDUFAF2-CI-830 subcomplex
(although SDS-PAGE demonstrated that NDUFAF2 was present; Fig. 5).
This lack of NDUFAF2-CI-830 subcomplex agrees with our previous
findings [56].
4.5. Summary and conclusions
Taken together, our results demonstrate that absence of NDUFS4
greatly reduces NDUFA12 levels but not vice versa. This suggests a
mono-directional stabilization of NDUFA12 by NDUFS4. We further
provide evidence that NDUFAF2 stabilizes functional CI in the absence
of NDUFA12 and presence of NDUFS4. The fact that absence of
NDUFAF2 did not induce formation of the CI-830 subcomplex but
lowered the levels of assembled and active CI in NDUFAF2 patient cells,
supports such a stabilizing role and suggests that NDUFAF2 is not a true
CI assembly factor but acts as a chaperone instead [61]. In the presence
of NDUFS4, NDUFAF2-mediated joining is quite strong since no discrete
CI subassemblies were observed in NDUFA12-mutated patient cells.
Integrating our findings (Fig. 5) supports a mechanism in which
NDUFAF2 stabilizes CI in situ, not only in the absence of NDUFS4 and/
or NDUFA12, but also in patient cells with mutations in NDUFV1 and
NDUFS1. The absence of NDUFS4 was associated with activity of CI in
situ but not on BN-PAGE, which revealed an inactive NDUFAF2-CI-830
subcomplex. This suggests that the impact of BN-PAGE solubilization
detergents on the level of assembled and active CI depends on CI sta-
bility. In this sense, our results not only highlight the crucial role of
NDUFS4 in CI stabilization but also demonstrate that NDUFAF2 is un-
able to maintain N- to Q-module attachment under BN-PAGE condi-
tions. Supporting the latter hypothesis, we have demonstrated the
presence of a detached (partial) N-module using BN-PAGE analysis of
Ndufs4−/− mouse tissues [60]. Since CI catalytic function requires N-
to-Q module attachment, we hypothesize that additional mechanisms
are involved to sustain CI in situ activity in Ndufs4−/− cells. Though
still poorly understood, it is well established that lipid composition
affects the conformation and activity of membrane-embedded proteins
[62]. Also assembly and/or stabilization of OXPHOS complexes criti-
cally depend on specific MIM lipids [63]. Therefore we propose a model
in which both NDUFAF2 and MIM lipids play a role in keeping the N-
and Q-module together in the dual absence of NDUFS4 and NDUFA12.
In this context, it might be possible that tissue-specific differences in
NDUFAF2-mediated CI stabilization and/or MIM lipid physicochemical
properties underlie the significantly greater reduction in CI subunit
level observed in brain and diaphragm of Ndufs4−/− mice.
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